Brief: Infant Bacterial Therapeutics CFO Leaves The Company
07/07/2026 11:18
BRIEF-Infant Bacterial Therapeutics CFO Leaves The Company July 7 (Reuters) - Infant Bacterial Therapeutics AB IBTb.ST:
CFO LEAVES THE COMPANY
MARIA EKDAHL, CFO, TO LEAVE INFANT BACTERIAL THERAPEUTICS ON OCTOBER 7
TO APPOINT EXTERNAL CONSULTANT AS INTERIM CFO
Source text: ID:nMFN28wy8D
Further company coverage: [IBTb.ST]
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln